vaxgen, biodefense, anthrax vaccine, smallpox vaccine, small pox vaccine, anthrax, smallpox, small pox, rpa102, lc16m8, biopharmaceutical, biologic, bioterrorism, us biodefense, biopharmaceutical company, biopharmaceutical companies, biopharmaceuticals, vaccine, vaccines, homeland security, biodefense vaccines, biodefense company, bioterror countermeasures, biochemical,recombinant technology, biologics contract manufacturing, biologic manufacturer, pre-exposure prophylaxis, post-exposure prophylaxis

vaxgen, inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. vaxgen is currently developing next-generation vaccines against anthrax and smallpox.